Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.5K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.2K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.2K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

15.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
15.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging local species data, a global database, and an occupancy model to explore bee-plant interactions.

Ecological applications : a publication of the Ecological Society of America·2026
Same author

Determining the Minimal Clinically Important Difference of the 40-Item Smell Identification Test in People With Cystic Fibrosis.

International forum of allergy & rhinology·2026
Same author

Mechanisms of disrupted neurodevelopment after Zika virus infection in infancy.

bioRxiv : the preprint server for biology·2026
Same author

Structural basis for the recruitment and selective phosphorylation of Akt by mTORC2.

Science (New York, N.Y.)·2025
Same author

Olfaction, Eating Preference, and Quality of Life in Cystic Fibrosis Chronic Rhinosinusitis.

The Laryngoscope·2025
Same author

Media influence on humanitarian interventions: analysis of the Rohingya refugee crisis and international media coverage.

Journal of international humanitarian action·2024
Same journal

Real-world long-term efficacy of chemoimmunotherapy in advanced stage small cell lung cancer.

Respiration; international review of thoracic diseases·2026
Same journal

Residual AHI Measurement from PAP Devices Versus Home Polygraphy: A Method Comparison Study Using Real World Data.

Respiration; international review of thoracic diseases·2026
Same journal

Unveiling Sex Differences in Severe Acute COPD Exacerbations requiring ICU admission: Evidence from a French Cohort.

Respiration; international review of thoracic diseases·2026
Same journal

Intrapleural Fibrinolytics use in Children with Pleural Empyema: Safe and Effective.

Respiration; international review of thoracic diseases·2026
Same journal

Learning Curve for Transbronchial Lung Cryobiopsy in Interstitial Lung Disease Diagnosis: A Multicenter Experience.

Respiration; international review of thoracic diseases·2026
Same journal

Follow-Up Care After Adult Lung Transplantation: Summary of an Evidence-Based Clinical Practice Guideline for German-Speaking Countries.

Respiration; international review of thoracic diseases·2026
See all related articles

Related Experiment Video

Updated: Mar 27, 2026

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
08:44

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

1.5K

Type 1 Diabetes Duration Decreases Pulmonary Diffusing Capacity during Exercise.

Michelle J Lee1, J Richard Coast, Steven C Hempleman

  • 1Northern Arizona University, Flagstaff, Ariz., USA.

Respiration; International Review of Thoracic Diseases
|January 13, 2016
PubMed
Summary
This summary is machine-generated.

Longer duration of type 1 diabetes (T1D) is linked to reduced lung diffusing capacity (DLCO) and its components, specifically alveolar-capillary membrane conductance (DM). Shorter diabetes duration showed no significant lung function changes.

More Related Videos

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

11.2K
Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
07:09

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise

Published on: February 20, 2017

13.9K

Related Experiment Videos

Last Updated: Mar 27, 2026

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
08:44

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies

Published on: February 2, 2024

1.5K
Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity
07:13

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

11.2K
Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
07:09

Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise

Published on: February 20, 2017

13.9K

Area of Science:

  • Pulmonary Medicine
  • Endocrinology
  • Diabetology

Background:

  • Diabetes mellitus impacts peripheral tissues, but its effects on lung function remain less understood.
  • Lung diffusing capacity (DLCO) is a key indicator of gas exchange, influenced by alveolar-capillary membrane conductance (DM) and pulmonary capillary blood volume (VC).
  • Previous studies indicate reduced DLCO, DM, and VC in adults with type 1 diabetes (T1D).

Purpose of the Study:

  • To investigate the association between diabetes duration and lung function parameters in type 1 diabetes.
  • To determine if diabetes duration influences lung diffusing capacity (DLCO), alveolar-capillary membrane conductance (DM), pulmonary capillary blood volume (VC), and cardiac output (Q).

Main Methods:

  • A cohort of 24 T1D patients and 24 non-diabetic controls were recruited.
  • Lung function tests including DLCO, DM, VC, and cardiac output (Q) were measured at rest and during incremental exercise (40%, 70%, 90% VO2max).
  • Patients were stratified by age and diabetes duration (short vs. long) for comparative analysis.

Main Results:

  • No significant differences in DLCO, DM, VC, or Q (normalized to body surface area [BSA]) were observed between age-stratified young and old groups.
  • Type 1 diabetes patients with long diabetes duration (9.6-28 years) exhibited significantly lower DLCO/BSA and DM/BSA compared to controls (p < 0.05).
  • No significant differences in lung function parameters were found in the short diabetes duration group (0.33-8.9 years).

Conclusions:

  • The duration of type 1 diabetes is a significant factor associated with impaired lung diffusing capacity.
  • Long-standing type 1 diabetes leads to measurable decrements in DLCO and its primary determinant, DM.
  • Early detection and management of diabetes complications may be crucial for preserving lung health.